Abstract

Introduction: Wilms’ tumor 1 antigen (WT1) expression in podocytes has the important role of maintaining their integrity and glomerular function. Vimentin also plays a role in preserving podocyte function and in morphological changes observed after injury. Corticotropin-releasing factor (CRF) is important in stress and in maintaining homeostasis. According to our previous studies, tyrosine (Tyr) isoforms (meta- and ortho-Tyr) may play a role in the development of many diseases. Methods: Our aim was to investigate the expression of WT1, vimentin, and CRF in the human kidney and in HEK 293 cell cultures. Histological and clinical features of 42 focal segmental glomerulosclerosis (FSGS) patients were evaluated and compared to those of patients with thin basement membrane as a control group. Cells were cultured in medium containing para-, meta-, and ortho-Tyr, and their expression of WT1, vimentin, and CRF were determined by immunocytochemistry. Podocyte foot process effacement was investigated by electron microscope. Results: The intensity of WT1 staining in glomeruli was the same in FSGS and control groups, but it was lower in the tubulointerstitium of FSGS patients. Vimentin was lower in glomeruli of FSGS patients (p = 0.009), and it was higher in the tubulointerstitium compared to the control group (p = 0.003). CRF intensity was lower in the glomeruli (p = 0.002). Podocyte foot process effacement determined by electron microscope showed correlation with vimentin and CRF in glomeruli. WT1 staining intensity was lower in meta- and ortho-Tyr group (p = 0.001; p = 0.009). Vimentin was lower in the meta-Tyr group (p = 0.001). Discussion: Our observations on kidney biopsy samples support that the reduction of WT1 and vimentin could be characteristic for FSGS. Our results on HEK cells suggest that meta- and ortho-Tyr may play a role in the development of FSGS.

© 2022 The Author(s). Published by S. Karger AG, Basel

References Testagrossa L, Azevedo Neto R, Resende A, Woronik V, Malheiros D. Immunohistochemical expression of podocyte markers in the variants of focal segmental glomerulosclerosis. Nephrol Dial Transpl. 2013 Jan;28(1):91–8. Iijima K, Someya T, Ito S, Nozu K, Nakanishi K, Matsuoka K, et al. Focal segmental glomerulosclerosis in patients with complete deletion of one WT1 allele. Pediatrics. 2012 Jun;129(6):e1621–5. Guo JK, Menke AL, Gubler MC, Clarke AR, Harrison D, Hammes A, et al. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet. 2002 Mar 15;11(6):651–9. Menke AL, Schedl A. WT1 and glomerular function. Semin Cell Dev Biol. 2003 Aug;14(4):233–40. Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, et al. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol. 2006 Jan;168(1):42–54. Stamenkovic I, Skalli O, Gabbiani G. Distribution of intermediate filament proteins in normal and diseased human glomeruli. Am J Pathol. 1986 Dec; 125(3):465–75. Omary MB, Coulombe PA, McLean WI. Intermediate filament proteins and their associated diseases. N Engl J Med. 2004 Nov 11;351(20):2087–100. Zou J, Yaoita E, Watanabe Y, Yoshida Y, Nameta M, Li H. Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch. 2006 Apr;448(4):485–92. Benardeau A, Verry P, Atzpodien EA, Funk JM, Meyer M, Mizrahi J, et al. Effects of the dual PPAR-α/γ agonist aleglitazar on glycaemic control and organ protection in the Zucker diabetic fatty rat. Diabetes Obes Metab. 2013 Feb;15(2):164–74. Majzoub JA. Corticotropin-releasing hormone physiology. Eur J Endocrinol. 2006;155(Suppl l_1):71–6. Duni A, Liakopoulos V, Roumeliotis S, Peschos D, Dounousi E. Oxidative stress in the pathogenesis and evolution of chronic kidney disease: untangling ariadne’s thread. Int J Mol Sci. 2019 Jul 29;20(15):3711. Sureshbabu A, Ryter SW, Choi ME. Oxidative stress and autophagy: crucial modulators of kidney injury. Redox Biol. 2015 Jan;4:208–14. Woolf LI, Jakubovic A, Chan-Henry E. The non-enzymic hydroxylation of phenylalanine to tyrosine by 2-amino-4-hydroxy-6, 7-dimethyl-5, 6, 7, 8-tetrahydropteridine. Biochem J. 1971 Nov;125(2):569–74. Molnár GA, Kun S, Sélley E, Kertész M, Szélig L, Csontos C, et al. Role of tyrosine isomers in acute and chronic diseases leading to oxidative stress: a review. Curr Med Chem. 2016;23(7):667–85. Molnár GA, Nemes V, Biró Z, Ludány A, Wagner Z, Wittmann I. Accumulation of the hydroxyl free radical markers meta-ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water-soluble phase. Free Radic Res. 2005 Dec;39(12):1359–66. Mikolás E, Kun S, Laczy B, Molnár GA, Sélley E, Kőszegi T. Incorporation of ortho- and meta-tyrosine into cellular proteins leads to erythropoietin-resistance in an erythroid cell line. Kidney Blood Press Res. 2013;38(2–3):217–25. Kun S, Mikolás E, Molnár GA, Sélley E, Laczy B, Csiky B, et al. Association of plasma ortho-tyrosine/para-tyrosine ratio with responsiveness of erythropoiesis-stimulating agent in dialyzed patients. Redox Rep. 2014 Sep;19(5):190–8. Molnár GA, Mikolás EZ, Szijártó IA, Kun S, Sélley E, Wittmann I. Tyrosine isomers and hormonal signaling: a possible role for the hydroxyl free radical in insulin resistance. World J Diabetes. 2015 Apr 15;6(3):500–7. Zhong J, Whitman JB, Yang HC, Fogo AB. Mechanisms of scarring in focal segmental glomerulosclerosis. J Histochem Cytochem. 2019 Sep;67(9):623–32. Stitt-Cavanagh E, MacLoed L, Kennedy CRJ. The podocyte in diabetic kidney disease. Scientific World J. 2009 Oct 14;9:1127–39. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol. 2008 Feb;172(2):299–308. Yamaguchi Y, Iwano M, Suzuki D, Nakatani K, Kimura K, Harada K, et al. Epithelial–mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis. 2009 Oct;54(4):653–64. Bottinger EP. TGF-in renal injury and disease. Semin Nephrol. 2007 May;27(3): 309–20. Kim JH, Kim BK, Moon KC, Hong HK, Lee HS. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis. Kidney Int. 2003 Nov;64(5):1715–21. Daehn I, Casalena G, Zhang T, Shi S, Fenninger F, Barasch N, et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest. 2014 Apr;124(4):1608–21. Liu RM, Desai LP. Reciprocal regulation of TGF-β and reactive oxygen species: a perverse cycle for fibrosis. Redox Biol. 2015 Dec;6:565–77. Ipson BR, Fisher AL. Roles of the tyrosine isomers meta-tyrosine and ortho-tyrosine in oxidative stress. Ageing Res Rev. 2016 May;27:93–107. Appel D, Kershaw DB, Smeets B, Yuan G, Fuss A, Frye B, et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol. 2009 Feb;20(2):333–43. Ohse T, Vaughan MR, Kopp JB, Krofft RD, Marshall CB, Chang AM, et al. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. Am J Physiol Ren Physiol. 2010 Mar;298(3):F702–11. Gebeshuber CA, Kornauth C, Dong L, Sierig R, Seibler J, Reiss M, et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med. 2013 Apr;19(4):481–7. Bachmann S, Kriz W, Kuhn C, Franke WW. Differentiation of cell types in the mammalian kidney by immunofluorescence microscopy using antibodies to intermediate filament proteins and desmoplakins. Histochemistry. 1983;77(3):365–94. Jercan O, Penescu M, Traşcă DM. Implications of tubulo-interstitial epithelial and mesenchymal relation in chronic kidney disease. Rom J Morphol Embryol. 2012;53(3 Suppl l):713–7. Rocha LP, Xavier SC, Helmo FR, Machado JR, Ramalho FS, Dos Reis MA. Epithelial-mesenchymal transition in pediatric nephropathies. Pathol Res Pract. 2016 Dec;212(12):1157–66. Farris AB, Colvin RB. Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens. 2012 May;21(3):289–300. Article / Publication Details

First-Page Preview

Received: April 08, 2022
Accepted: December 11, 2022
Published online: December 16, 2022

Number of Print Pages: 10
Number of Figures: 5
Number of Tables: 2

ISSN: 1420-4096 (Print)
eISSN: 1423-0143 (Online)

For additional information: https://www.karger.com/KBR

Figures Tables